Scalable Synthesis and New Bond Disconnections
Scalable Synthesis and New Bond Disconnections
批准号:
10373114
负责人:
PHIL S BARAN
金额:
$109.42万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
未结题
起止时间:
2016-04-01 至 2026-03-31
关键词:
AddressAdoptionAlkaloidsArchitectureBiochemical PathwayBiologicalBiomedical ResearchBreathingChemicalsCollaborationsComplexDevelopmentDrug IndustryEnvironmentFDA approvedFamilyFolk MedicineHuman bodyIndustrializationKnowledgeLaboratoriesLiteratureMediator of activation proteinMethodologyMethodsModernizationNatural ProductsNatureOrganic ChemistryPharmaceutical ChemistryPharmaceutical PreparationsPharmacologic SubstanceProceduresPropertyReagentResearchScientistSourceSynthesis ChemistryTerpenesTranscendcostdrug discoveryfield studyinterestnovelprogramsscaffoldsuccess
中文摘要
项目总结/摘要
天然产品作为民间药物长期以来一直具有社会价值,即使在现代,
许多FDA批准的药物仍然来源于自然界中发现的萜烯和生物碱。
生物医学研究也受益于天然产品,这是以前所不知道的
在研究独特的生物化学途径时,
这些化合物在人体内的作用。此外,在全合成方面的努力
这些结构上不同的化合物不断地给化学家带来挑战,
这反过来又导致了学术和工业研究项目的建立
环境.自成立以来,我们的实验室一直在追求,并取得了成功,
萜类和生物碱类标志性天然产物的全合成。这些
合成已经确定了化学文献中的空白,我们随后对此进行了讨论。
这项研究计划的产物-新的合成策略,前所未有的转变
和新型试剂-反过来又使合成更天然的产品成为可能,
药物相关的基序,从而完成发现的催化循环。我们寻求
复制这一成功与目前的建议:所描述的项目将针对复杂的自然
产品,以确定化学方法的缺点,同时制定
方法,然后评估其在综合中的实用性。
复杂的分子。在接下来的五年里,我们的实验室将产生化学知识,
超越了天然产物合成的最初目标。我们将专注于高效
以合成理想的复杂天然产物为目标。我们还将开发有用的方法
用于合成和药物化学。由此产生的程序将用于建设
复杂的药物图案,这将有助于扩大化学空间和加速
药物发现中的发现值得注意的是,我们已经建立了许多合作,
研究将要合成的产品的生物特性,以验证和现场测试
新的方法,并将试剂商业化,以广泛采用学术和
工业环境。最后,我们将重点关注合成橡胶的战略应用和发展。
有机电化学方法,其中C-H的氧化介体的开发
提出了官能化、羰基的去饱和和还原性交叉偶联。
英文摘要
PROJECT SUMMARY/ABSTRACT
Natural products have long held societal value as folk medicines, and even in this modern era,
many FDA-approved drugs are still being derived from terpenes and alkaloids found in nature.
Biomedical research has also benefited from natural products, as previously unknown
mechanisms of action have been discovered while studying the unique biochemical pathways
that these compounds undergo in the human body. Furthermore, endeavors in the total synthesis
of these architecturally diverse compounds have continuously provided chemists with challenges,
which in turn have led to the establishment of research programs in both academic and industrial
environments. Ever since its inception, our laboratory has been pursuing, and has succeeded in,
the total synthesis of iconic natural products in both the terpene and alkaloid families. These
syntheses have identified gaps in the chemical literature, which we have subsequently addressed.
The products of this research program—new synthetic strategies, unprecedented transformations
and novel reagents—have in turn enabled the synthesis of even more natural products and
pharmaceutically relevant motifs, thus completing a catalytic cycle of discovery. We seek to
replicate this success with the current proposal: the described projects will target complex natural
products to identify shortcomings in chemical methodology, while simultaneously devising
methods of widespread interest, followed by the assessment of their practicality in the synthesis
of complex molecules. For the next five years our laboratory will generate chemical knowledge
that transcends the original objective of natural product synthesis. We will focus on efficiently
synthesize complex natural products aiming for ideality. We will also develop of useful methods
for synthesis and medicinal chemistry. The resulting procedures will be utilized in the construction
of complex pharmaceutical motifs, which will serve to expand chemical space and accelerate
discovery in drug discovery. Notably, we have already established numerous collaborations to
study the biological properties of the products that will be synthesized, to validate and field-test
new methods, and to commercialize reagents for widespread adoption in both academic and
industrial settings. Lastly, we will focus on strategic applications and development of synthetic
organic electrochemical methods, wherein the development of oxidative mediators for C-H
functionalization, desaturation of carbonyls, and reductive cross-couplings are presented.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Scalable Synthesis and New Bond Disconnections
-
批准号:9891858
-
项目类别:
-
资助金额:$118.42万
-
财政年份:2016
-
负责人:PHIL S BARAN
-
依托单位:
Scalable Synthesis and New Bond Disconnections
-
批准号:10580740
-
项目类别:
-
资助金额:$111.58万
-
财政年份:2016
-
负责人:PHIL S BARAN
-
依托单位:
Scalable Synthesis and New Bond Disconnections
-
批准号:10164654
-
项目类别:
-
资助金额:$109.42万
-
财政年份:2016
-
负责人:PHIL S BARAN
-
依托单位:
Scalable Synthesis and New Bond Disconnections
-
批准号:9677411
-
项目类别:
-
资助金额:$9.62万
-
财政年份:2016
-
负责人:PHIL S BARAN
-
依托单位:
Transcriptional silencing of latent HIV infection - a novel small molecule class
-
批准号:8731293
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2014
-
负责人:PHIL S BARAN
-
依托单位:
Preparative Radical Chemistry for Biomedical Research
-
批准号:8996063
-
项目类别:
-
资助金额:$51.73万
-
财政年份:2013
-
负责人:PHIL S BARAN
-
依托单位:
Preparative Radical Chemistry for Biomedical Research
-
批准号:8795737
-
项目类别:
-
资助金额:$51.73万
-
财政年份:2013
-
负责人:PHIL S BARAN
-
依托单位:
Preparative Radical Chemistry for Biomedical Research
-
批准号:8485337
-
项目类别:
-
资助金额:$51.73万
-
财政年份:2013
-
负责人:PHIL S BARAN
-
依托单位:
Synthesis of Complex Terpenes
-
批准号:8636031
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2011
-
负责人:PHIL S BARAN
-
依托单位:
Synthesis of Complex Terpenes
-
批准号:8242687
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2011
-
负责人:PHIL S BARAN
-
依托单位:
Synthesis of Complex Terpenes
-
批准号:8080703
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2011
-
负责人:PHIL S BARAN
-
依托单位:
Synthesis of Complex Terpenes
-
批准号:8446414
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2011
-
负责人:PHIL S BARAN
-
依托单位:
Total Synthesis of Anti-Cancer Natural Products
-
批准号:7674771
-
项目类别:
-
资助金额:$63.05万
-
财政年份:2009
-
负责人:PHIL S BARAN
-
依托单位:
Oxidative Coupling in Natural Product Synthesis
-
批准号:7105690
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2006
-
负责人:PHIL S BARAN
-
依托单位:
Oxidative Coupling in Natural Product Synthesis
-
批准号:7413407
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2006
-
负责人:PHIL S BARAN
-
依托单位:
Oxidative Coupling in Natural Product Synthesis
-
批准号:7225605
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2006
-
负责人:PHIL S BARAN
-
依托单位:
Oxidative Coupling in Natural Product Synthesis
-
批准号:7614176
-
项目类别:
-
资助金额:$35.42万
-
财政年份:2006
-
负责人:PHIL S BARAN
-
依托单位:
Synthesis of Pyrrole-Imidazole Alkaloids
-
批准号:7616104
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2005
-
负责人:PHIL S BARAN
-
依托单位:
Synthesis of Pyrrole-Imidazole Alkaloids
-
批准号:6908565
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2005
-
负责人:PHIL S BARAN
-
依托单位:
Synthesis of Pyrrole-Imidazole Alkaloids
-
批准号:8267033
-
项目类别:
-
资助金额:$43.91万
-
财政年份:2005
-
负责人:PHIL S BARAN
-
依托单位:
海外基金